Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 8Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 104Lymphoma 78Lung Neoplasms 68Colorectal Neoplasms 61Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 58Leukemia 56Colonic Neoplasms 56Lymphoma, Follicular 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Central Nervous System Neoplasms 39Lymphoma, Large B-Cell, Diffuse 38Prostatic Neoplasms 35Ovarian Neoplasms 33Melanoma 33Lymphoma, Non-Hodgkin 33Head and Neck Neoplasms 32Burkitt Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 30Carcinoma, Ovarian Epithelial 30Lymphoma, Large-Cell, Immunoblastic 28Kidney Neoplasms 28Multiple Myeloma 26Lymphoma, Mantle-Cell 26Lymphoma, B-Cell, Marginal Zone 25Carcinoma, Renal Cell 25Sarcoma 24Neoplasms, Plasma Cell 24Leukemia, Myeloid, Acute 24Hodgkin Disease 23

Interventions

lerisetron 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Granisetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NIH × Seminoma × Clear all
NCT00589537 2013-08-07

Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle

National Cancer Institute (NCI)

Phase 3 Unknown
660 enrolled
Genitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms, Seminoma

NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡